7 Tesla Clinical functional Magnetic Resonance Imaging.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004505

Enrollment

Registered

2012-10-24

Start date

2012-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.9 G40.9

Interventions

Group 1: functional Magnetic Resonance Imaging investigations of healthy subject to develop methods Group 2: functional Magnetic Resonance Imaging investigations of neurological patients to test impro

Eligibility

Sex/Gender

All

Age

5 Years to No maximum

Inclusion criteria

Inclusion criteria: For the patient cohort: minimum age 5 years, and neurological pathologies leading to referral for fMRI localisation (primarily epilepsy or brain tumours). For the healthy subject group, minimum 18 years, no known neurological pathologies.

Exclusion criteria

Exclusion criteria: Pregnancy, contraindications for MR imaging (such as cardiac pacemaker, aneurysm clips. For volunteers, disease of the central nervous system.

Design outcomes

Primary

Measure	Time frame
Improvement in quality of functional Magnetic Resonance Imaging results in healthy subjects and neurological patients, quantified by reduced Nyquist ghosting, increased BOLD sensitivity and other measures of image quality, including distortion and signal-to-noise ratio.	—

Secondary

Measure	Time frame
Establishing methods for dynamic distortion correction of 7 Tesla fMRI data.	—

Countries

Austria

Contacts

Public ContactSimon Robinson

MR Centre of Excellence, Department of Radiology, Medical University of Vienna

simon.robinson@meduniwien.ac.at+43-1-40400-6468

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026